It is responsible for driving fatty acids to the mitochondria where it is used as fuel for energy production
Nature Reviews Endocrinology.
More specifically speaking, the mechanism potentially involved downregulation of macrophage CD11b, which played a vital role in monocyte adhesion, as well as decreased expression of macrophage modulators including CXCL-10, CXCL-1, C-C motif chemokine ligand-1 (CCL-2) and tissue inhibitor of metal protease-1 (TIMP-1) (Robinson et al., 2015)
Many of the formulations we use in our therapies are not covered by insurance, and the cost of overall treatment is often less than when using insurance
GENAXXON biosciences) to confirm their biological function
Back Holst, JJ (26 April 2019) 'From the Incretin Concept and the discovery of GLP-1 to today's diabetes therapy', Frontiers in Endocrinology , 10